1. Home
  2. YYAI vs LYRA Comparison

YYAI vs LYRA Comparison

Compare YYAI & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YYAI
  • LYRA
  • Stock Information
  • Founded
  • YYAI 2015
  • LYRA 2005
  • Country
  • YYAI Hong Kong
  • LYRA United States
  • Employees
  • YYAI N/A
  • LYRA N/A
  • Industry
  • YYAI
  • LYRA Medical/Dental Instruments
  • Sector
  • YYAI
  • LYRA Health Care
  • Exchange
  • YYAI NYSE
  • LYRA Nasdaq
  • Market Cap
  • YYAI 12.1M
  • LYRA 13.5M
  • IPO Year
  • YYAI N/A
  • LYRA 2020
  • Fundamental
  • Price
  • YYAI $0.64
  • LYRA $0.21
  • Analyst Decision
  • YYAI
  • LYRA Buy
  • Analyst Count
  • YYAI 0
  • LYRA 5
  • Target Price
  • YYAI N/A
  • LYRA $4.50
  • AVG Volume (30 Days)
  • YYAI 1.7M
  • LYRA 907.8K
  • Earning Date
  • YYAI 03-04-2025
  • LYRA 03-20-2025
  • Dividend Yield
  • YYAI N/A
  • LYRA N/A
  • EPS Growth
  • YYAI N/A
  • LYRA N/A
  • EPS
  • YYAI N/A
  • LYRA N/A
  • Revenue
  • YYAI N/A
  • LYRA $1,471,000.00
  • Revenue This Year
  • YYAI N/A
  • LYRA N/A
  • Revenue Next Year
  • YYAI N/A
  • LYRA N/A
  • P/E Ratio
  • YYAI N/A
  • LYRA N/A
  • Revenue Growth
  • YYAI N/A
  • LYRA 3.37
  • 52 Week Low
  • YYAI $0.35
  • LYRA $0.16
  • 52 Week High
  • YYAI $53.00
  • LYRA $6.79
  • Technical
  • Relative Strength Index (RSI)
  • YYAI 47.76
  • LYRA 57.63
  • Support Level
  • YYAI $0.35
  • LYRA $0.19
  • Resistance Level
  • YYAI $0.67
  • LYRA $0.22
  • Average True Range (ATR)
  • YYAI 0.07
  • LYRA 0.01
  • MACD
  • YYAI 0.07
  • LYRA 0.00
  • Stochastic Oscillator
  • YYAI 90.66
  • LYRA 66.75

About YYAI CONNEXA SPORTS TECHNOLOGIES IN

Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: